Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy.

Kim CH, Koo BK, Dehbi HM, Lee JM, Doh JH, Nam CW, Shin ES, Cook CM, Al-Lamee R, Petraco R, Sen S, Malik IS, Nijjer SS, Mejía-Rentería H, Alegria-Barrero E, Alghamdi A, Altman J, Baptista SB, Bhindi R, Bojara W, Brugaletta S, Silva PC, Di Mario C, Erglis A, Gerber RT, Going O, Härle T, Hellig F, Indolfi C, Janssens L, Jeremias A, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Laine M, Lehman SJ, Matsuo H, Meuwissen M, Niccoli G, Piek JJ, Ribichini F, Samady H, Sapontis J, Seto AH, Sezer M, Sharp ASP, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Vinhas H, Vrints CJ, Walters D, Yokoi H, Samuels B, Buller C, Patel MR, Serruys PW, Escaned J, Davies JE.

JACC Cardiovasc Interv. 2019 Oct 28;12(20):2035-2046. doi: 10.1016/j.jcin.2019.06.035.

PMID:
31648764
2.

Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.

DEFINE-FLAIR Trial Investigators, Lee JM, Choi KH, Koo BK, Dehbi HM, Doh JH, Nam CW, Shin ES, Cook CM, Al-Lamee R, Petraco R, Sen S, Malik IS, Nijjer SS, Mejía-Rentería H, Alegria-Barrero E, Alghamdi A, Altman J, Baptista SB, Bhindi R, Bojara W, Brugaletta S, Silva PC, Di Mario C, Erglis A, Gerber RT, Going O, Härle T, Hellig F, Indolfi C, Janssens L, Jeremias A, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Laine M, Lehman SJ, Matsuo H, Meuwissen M, Niccoli G, Piek JJ, Ribichini F, Samady H, Sapontis J, Seto AH, Sezer M, Sharp ASP, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Vinhas H, Vrints CJ, Walters D, Yokoi H, Samuels B, Buller C, Patel MR, Serruys P, Escaned J, Davies JE.

JAMA Cardiol. 2019 Jul 17. doi: 10.1001/jamacardio.2019.2298. [Epub ahead of print]

PMID:
31314045
3.

Thyroid cancer recurrence in the HiLo trial - Authors' reply.

Hackshaw A, Dehbi HM.

Lancet Diabetes Endocrinol. 2019 Apr;7(4):252-253. doi: 10.1016/S2213-8587(19)30088-9. No abstract available.

PMID:
30902263
4.

A Double-Blind Placebo-Controlled Crossover Study of the Effect of Beetroot Juice Containing Dietary Nitrate on Aortic and Brachial Blood Pressure Over 24 h.

Kukadia S, Dehbi HM, Tillin T, Coady E, Chaturvedi N, Hughes AD.

Front Physiol. 2019 Feb 4;10:47. doi: 10.3389/fphys.2019.00047. eCollection 2019.

5.

Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment.

Sen S, Ahmad Y, Dehbi HM, Howard JP, Iglesias JF, Al-Lamee R, Petraco R, Nijjer S, Bhindi R, Lehman S, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, Härle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Silva PC, Baptista SB, Alghamdi A, Hellig F, Koo BK, Nam CW, Shin ES, Doh JH, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J, Davies JE.

J Am Coll Cardiol. 2019 Feb 5;73(4):444-453. doi: 10.1016/j.jacc.2018.10.070.

6.

Application of the DILEMMA score to improve lesion selection for invasive physiological assessment.

Michail M, Dehbi HM, Nerlekar N, Davies JE, Sharp ASP, Talwar S, Cameron JD, Brown AJ, Wong DT, Mathur A, Hughes AD, Narayan O.

Catheter Cardiovasc Interv. 2019 Sep 1;94(3):E96-E103. doi: 10.1002/ccd.28054. Epub 2019 Jan 2.

PMID:
30604558
7.

Reply: Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements.

Escaned J, Mejía-Rentería H, Dehbi HM, Gotberg M, Davies J.

JACC Cardiovasc Interv. 2018 Dec 10;11(23):2435. doi: 10.1016/j.jcin.2018.10.034. No abstract available.

PMID:
30522678
8.

Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.

Dehbi HM, Mallick U, Wadsley J, Newbold K, Harmer C, Hackshaw A.

Lancet Diabetes Endocrinol. 2019 Jan;7(1):44-51. doi: 10.1016/S2213-8587(18)30306-1. Epub 2018 Nov 27.

9.

Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes.

Escaned J, Ryan N, Mejía-Rentería H, Cook CM, Dehbi HM, Alegria-Barrero E, Alghamdi A, Al-Lamee R, Altman J, Ambrosia A, Baptista SB, Bertilsson M, Bhindi R, Birgander M, Bojara W, Brugaletta S, Buller C, Calais F, Silva PC, Carlsson J, Christiansen EH, Danielewicz M, Di Mario C, Doh JH, Erglis A, Erlinge D, Gerber RT, Going O, Gudmundsdottir I, Härle T, Hauer D, Hellig F, Indolfi C, Jakobsen L, Janssens L, Jensen J, Jeremias A, Kåregren A, Karlsson AC, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Koo BK, Koul S, Laine M, Lehman SJ, Lindroos P, Malik IS, Maeng M, Matsuo H, Meuwissen M, Nam CW, Niccoli G, Nijjer SS, Olsson H, Olsson SE, Omerovic E, Panayi G, Petraco R, Piek JJ, Ribichini F, Samady H, Samuels B, Sandhall L, Sapontis J, Sen S, Seto AH, Sezer M, Sharp ASP, Shin ES, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Varenhorst C, Vinhas H, Vrints CJ, Walters D, Yokoi H, Fröbert O, Patel MR, Serruys P, Davies JE, Götberg M.

JACC Cardiovasc Interv. 2018 Aug 13;11(15):1437-1449. doi: 10.1016/j.jcin.2018.05.029.

10.

Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.

Al-Lamee R, Howard JP, Shun-Shin MJ, Thompson D, Dehbi HM, Sen S, Nijjer S, Petraco R, Davies J, Keeble T, Tang K, Malik IS, Cook C, Ahmad Y, Sharp ASP, Gerber R, Baker C, Kaprielian R, Talwar S, Assomull R, Cole G, Keenan NG, Kanaganayagam G, Sehmi J, Wensel R, Harrell FE, Mayet J, Thom SA, Davies JE, Francis DP.

Circulation. 2018 Oct 23;138(17):1780-1792. doi: 10.1161/CIRCULATIONAHA.118.033801.

11.

A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study.

Crossan C, Dehbi HM, Williams H, Poulter N, Rodgers A, Jan S, Thom S, Lord J.

BMJ Open. 2018 Mar 14;8(3):e013063. doi: 10.1136/bmjopen-2016-013063. Review.

12.

Effects of disease severity distribution on the performance of quantitative diagnostic methods and proposal of a novel 'V-plot' methodology to display accuracy values.

Petraco R, Dehbi HM, Howard JP, Shun-Shin MJ, Sen S, Nijjer SS, Mayet J, Davies JE, Francis DP.

Open Heart. 2018 Jan 20;5(1):e000663. doi: 10.1136/openhrt-2017-000663. eCollection 2018.

13.

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.

Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, Keeble T, Mielewczik M, Kaprielian R, Malik IS, Nijjer SS, Petraco R, Cook C, Ahmad Y, Howard J, Baker C, Sharp A, Gerber R, Talwar S, Assomull R, Mayet J, Wensel R, Collier D, Shun-Shin M, Thom SA, Davies JE, Francis DP; ORBITA investigators.

Lancet. 2018 Jan 6;391(10115):31-40. doi: 10.1016/S0140-6736(17)32714-9. Epub 2017 Nov 2. Erratum in: Lancet. 2018 Jan 6;391(10115):30.

14.

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.

Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, Rothermundt C, Wood Z, Benson C, Ali N, Marples M, Veal GJ, Jamieson D, Küver K, Tirabosco R, Forsyth S, Nash S, Dehbi HM, Beare S.

Lancet Oncol. 2017 Oct;18(10):1397-1410. doi: 10.1016/S1470-2045(17)30622-8. Epub 2017 Sep 4.

15.

Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Bennett A, Chow CK, Chou M, Dehbi HM, Webster R, Salam A, Patel A, Neal B, Peiris D, Thakkar J, Chalmers J, Nelson M, Reid C, Hillis GS, Woodward M, Hilmer S, Usherwood T, Thom S, Rodgers A.

Hypertension. 2017 Jul;70(1):85-93. doi: 10.1161/HYPERTENSIONAHA.117.09202. Epub 2017 Jun 5. Review.

16.

Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards.

Dehbi HM, Royston P, Hackshaw A.

BMJ. 2017 May 25;357:j2250. doi: 10.1136/bmj.j2250. No abstract available.

17.

Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI.

Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS, Bhindi R, Lehman SJ, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, Härle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Canas Silva P, Baptista SB, Alghamdi A, Hellig F, Koo BK, Nam CW, Shin ES, Doh JH, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J.

N Engl J Med. 2017 May 11;376(19):1824-1834. doi: 10.1056/NEJMoa1700445. Epub 2017 Mar 18.

18.

Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.

Chow CK, Thakkar J, Bennett A, Hillis G, Burke M, Usherwood T, Vo K, Rogers K, Atkins E, Webster R, Chou M, Dehbi HM, Salam A, Patel A, Neal B, Peiris D, Krum H, Chalmers J, Nelson M, Reid CM, Woodward M, Hilmer S, Thom S, Rodgers A.

Lancet. 2017 Mar 11;389(10073):1035-1042. doi: 10.1016/S0140-6736(17)30260-X. Epub 2017 Feb 10.

19.

Investigating Subgroup Effects in Randomized Clinical Trials.

Dehbi HM, Hackshaw A.

J Clin Oncol. 2017 Jan 10;35(2):253-254. Epub 2016 Oct 31. Review. No abstract available.

PMID:
28056207
20.

Air pollution and cardiovascular mortality with over 25years follow-up: A combined analysis of two British cohorts.

Dehbi HM, Blangiardo M, Gulliver J, Fecht D, de Hoogh K, Al-Kanaani Z, Tillin T, Hardy R, Chaturvedi N, Hansell AL.

Environ Int. 2017 Feb;99:275-281. doi: 10.1016/j.envint.2016.12.004. Epub 2016 Dec 7.

21.

Associations of night-time road traffic noise with carotid intima-media thickness and blood pressure: The Whitehall II and SABRE study cohorts.

Halonen JI, Dehbi HM, Hansell AL, Gulliver J, Fecht D, Blangiardo M, Kelly FJ, Chaturvedi N, Kivimäki M, Tonne C.

Environ Int. 2017 Jan;98:54-61. doi: 10.1016/j.envint.2016.09.023. Epub 2016 Oct 3.

22.

A novel curve fitting method for AV optimisation of biventricular pacemakers.

Dehbi HM, Jones S, Sohaib SM, Finegold JA, Siggers JH, Stegemann B, Whinnett ZI, Francis DP.

Physiol Meas. 2015 Sep;36(9):1889-900. doi: 10.1088/0967-3334/36/9/1889. Epub 2015 Aug 6.

23.

Ethnic differences in associations between fat deposition and incident diabetes and underlying mechanisms: the SABRE study.

Eastwood SV, Tillin T, Dehbi HM, Wright A, Forouhi NG, Godsland I, Whincup P, Sattar N, Hughes AD, Chaturvedi N.

Obesity (Silver Spring). 2015 Mar;23(3):699-706. doi: 10.1002/oby.20997. Epub 2015 Feb 3.

24.

Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis.

Nowbar AN, Mielewczik M, Karavassilis M, Dehbi HM, Shun-Shin MJ, Jones S, Howard JP, Cole GD, Francis DP; DAMASCENE writing group.

BMJ. 2014 Apr 28;348:g2688. doi: 10.1136/bmj.g2688. Review.

25.

Characterization of the left atrial neural network and its impact on autonomic modification procedures.

Malcolme-Lawes LC, Lim PB, Wright I, Kojodjojo P, Koa-Wing M, Jamil-Copley S, Dehbi HM, Francis DP, Davies DW, Peters NS, Kanagaratnam P.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):632-40. doi: 10.1161/CIRCEP.113.000193. Epub 2013 Apr 11.

PMID:
23580743
26.

A 64,489-patient full-disclosure database of cardiovascular risk factors and events status analysed in a Bayesian framework: a unique contribution to predictive science.

Dehbi HM, Francis DP.

Int J Cardiol. 2013 Apr 30;165(1):3-6. doi: 10.1016/j.ijcard.2012.09.209. Epub 2012 Nov 20.

PMID:
23174175

Supplemental Content

Loading ...
Support Center